IceCure Medical Ratios (2020-2026) | ICCM

Ratios Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Profitability
Gross Margin (Quarter)
39.87%52.72%46.46%58.10%50.20%26.18%49.09%45.07%46.32%-7.03%45.34%36.20%52.42%35.50%47.66%30.07%24.95%32.59%46.91%32.38%
EBT Margin (Quarter)
400.78%418.50%-1,179.19%592.37%559.61%646.85%-3,146.54%557.32%435.54%1,260.86%-2,210.12%491.25%319.29%648.49%517.14%504.41%644.76%451.29%329.63%466.19%
EBIT Margin (Quarter)
400.78%418.50%-1,179.19%592.37%559.61%646.85%-3,146.54%557.32%435.54%1,260.86%-2,210.12%491.25%319.29%648.49%517.14%504.41%644.76%451.29%329.63%466.19%
EBITDA Margin (Quarter)
400.78%418.50%-1,179.19%592.37%559.61%646.85%-3,146.54%557.32%435.54%1,260.86%-2,210.12%491.25%319.29%648.49%517.14%504.41%644.76%451.29%329.63%466.19%
Operating Margin (Quarter)
400.78%418.50%-1,179.19%592.37%559.61%646.85%-3,146.54%557.32%435.54%1,260.86%-2,210.12%491.25%319.29%648.49%517.14%504.41%644.76%451.29%329.63%466.19%
Net Margin (Quarter)
400.78%418.50%-1,179.19%592.37%559.61%646.85%-3,146.54%557.32%435.54%1,260.86%-2,210.12%491.25%319.29%648.49%517.14%504.41%644.76%451.29%329.63%466.19%
FCF Margin (Quarter)
-241.76%-446.70%-490.03%-390.36%-449.15%-476.50%-618.74%-378.45%-416.12%-997.25%-253.63%-380.08%-233.14%-471.45%-478.86%-556.14%-531.43%-317.88%-392.03%-463.23%
Efficiency
Inventory Average (Quarter)
1.62M1.86M2.14M2.49M2.67M1,429.85M1,429.96M2.84M2.70M2.46M2.19M2.04M1.98M1.98M2.01M2.18M2.52M2.67M2.64M
Assets Average (Quarter)
20.67M25.98M30.50M26.26M21.95M25.14M28.53M24.79M21.06M17.92M16.23M15.71M15.32M13.93M11.84M10.85M12.83M14.48M13.60M
Invested Capital (Quarter)
26.96M25.42M12.16M6.90M9.05M
Asset Utilization Ratio (Quarter)
0.200.160.110.140.160.120.110.130.140.180.200.210.240.240.280.260.230.230.26
Leverage & Solvency
Debt to Equity (Quarter)
0.020.020.00
Debt Ratio (Quarter)
0.030.030.020.010.000.000.010.00
Equity Ratio (Quarter)
0.840.840.740.550.65
Valuation
Enterprise Value (Quarter)
-18.61M-15.38M-25.62M-22.36M-17.73M-12.73M-321.62M-5.89M-16.68M-4.12M-11.06M-10.97M-11.34M-10.67M-7.56M-6.04M-5.38M-10.01M-8.90M-8.12M
Return Ratios
Return on Sales (Quarter)
0.04%0.04%-0.12%0.06%0.06%0.06%-0.31%0.06%0.04%0.13%-0.22%0.05%0.03%0.06%0.05%0.05%0.06%0.05%0.03%0.05%
Return on Capital Employed (Quarter)
-3.14%-44.28%-25.41%-21.72%-19.86%0.39%-71.57%-83.17%-103.47%-110.90%-130.98%-149.08%-160.48%186.57%229.44%494.47%217.39%156.27%178.40%
Return on Assets (Quarter)
0.00%0.00%0.00%0.00%0.00%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%0.01%0.01%0.01%0.01%0.01%0.01%